Advertisement

Ads Placeholder
Loading...

Bluelinea SA

ALBLU.PAEURONEXT
Healthcare
Medical - Devices
0.49
0.00(0.00%)
U.S. Market opens in 7h 24m

Bluelinea SA Fundamental Analysis

Bluelinea SA (ALBLU.PA) shows weak financial fundamentals with a PE ratio of -8.19, profit margin of -7.34%, and ROE of -71.13%. The company generates $0.0B in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

Cash Position10.47%
PEG Ratio-0.20

Areas of Concern

ROE-71.13%
Operating Margin-6.78%
Current Ratio0.46
We analyze ALBLU.PA's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -93.0/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-93.0/100

We analyze ALBLU.PA's fundamental strength across five key dimensions:

Efficiency Score

Weak

ALBLU.PA struggles to generate sufficient returns from assets.

ROA > 10%
-7.93%

Valuation Score

Excellent

ALBLU.PA trades at attractive valuation levels.

PE < 25
-8.19
PEG Ratio < 2
-0.20

Growth Score

Weak

ALBLU.PA faces weak or negative growth trends.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Weak

ALBLU.PA carries high financial risk with limited liquidity.

Debt/Equity < 1
7.48
Current Ratio > 1
0.46

Profitability Score

Weak

ALBLU.PA struggles to sustain strong margins.

ROE > 15%
-7113.08%
Net Margin ≥ 15%
-7.34%
Positive Free Cash Flow
No

Key Financial Metrics

Is ALBLU.PA Expensive or Cheap?

P/E Ratio

ALBLU.PA trades at -8.19 times earnings. This suggests potential undervaluation.

-8.19

PEG Ratio

When adjusting for growth, ALBLU.PA's PEG of -0.20 indicates potential undervaluation.

-0.20

Price to Book

The market values Bluelinea SA at 8.73 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.

8.73

EV/EBITDA

Enterprise value stands at -0.83 times EBITDA. This is generally considered low.

-0.83

How Well Does ALBLU.PA Make Money?

Net Profit Margin

For every $100 in sales, Bluelinea SA keeps $-7.34 as profit after all expenses.

-7.34%

Operating Margin

Core operations generate -6.78 in profit for every $100 in revenue, before interest and taxes.

-6.78%

ROE

Management delivers $-71.13 in profit for every $100 of shareholder equity.

-71.13%

ROA

Bluelinea SA generates $-7.93 in profit for every $100 in assets, demonstrating efficient asset deployment.

-7.93%

Following the Money - Real Cash Generation

Operating Cash Flow

Bluelinea SA generates limited operating cash flow of $498.10K, signaling weaker underlying cash strength.

$498.10K

Free Cash Flow

Bluelinea SA generates weak or negative free cash flow of $-953.60K, restricting financial flexibility.

$-953.60K

FCF Per Share

Each share generates $-0.05 in free cash annually.

$-0.05

FCF Yield

ALBLU.PA converts -7.30% of its market value into free cash.

-7.30%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-8.19

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.20

vs 25 benchmark

P/B Ratio

Price to book value ratio

8.73

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.87

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

7.48

vs 25 benchmark

Current Ratio

Current assets to current liabilities

0.46

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.71

vs 25 benchmark

ROA

Return on assets percentage

-0.08

vs 25 benchmark

ROCE

Return on capital employed

-0.20

vs 25 benchmark

How ALBLU.PA Stacks Against Its Sector Peers

MetricALBLU.PA ValueSector AveragePerformance
P/E Ratio-8.1928.54 Better (Cheaper)
ROE-71.13%738.00% Weak
Net Margin-7.34%-43982.00% (disorted) Weak
Debt/Equity7.480.34 Weak (High Leverage)
Current Ratio0.462806.01 Weak Liquidity
ROA-7.93%-14624.00% (disorted) Weak

ALBLU.PA outperforms its industry in 1 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Bluelinea SA's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Growth, Innovation

EPS CAGR

N/A

Industry Style: Defensive, Growth, Innovation

FCF CAGR

N/A

Industry Style: Defensive, Growth, Innovation

Fundamental Analysis FAQ